Others have shown PMCA2 deficiency leads to increased sensitivity to Ca2+-induced apoptosis19, and we hypothesized that PMCA2 suppression may enhance the effects of cytotoxic chemotherapy on breast cancer cells. Here, ATP2B2 is linked to breast cancer.